Global /China /Healthcare /Drug Manufacturers - General /600211

Tibet Rhodiola Pharmaceutical Holding Co.

600211

• SSE: 600211 • Delayed

40.46CNY -1.8%

5.98 USD

As of 16 June 2026, Tibet Rhodiola Pharmaceutical Holding Co. has a market cap of $1.96B USD, ranking #7149 globally and #1758 in China. It ranks #575 in the Healthcare sector, and #226 in the Drug Manufacturers - General industry.

Global Rank

7149

Country Rank

1758

Sector Rank

575

Industry Rank

226

Key Stats

Market Cap

$1.96BUSD

13.28B CNY

Enterprise Value

$1.63BUSD

11.01B CNY

Revenue (TTM)

$440.31MUSD

2.98B CNY

EBITDA (TTM)

$148.08MUSD

1.0B CNY

Net Income (TTM)

$138.51MUSD

937.93M CNY

EBITDA Margin

34%

Profit Margin

31%

PE Ratio

14.2

PS Ratio

4.5

PB Ratio

3.2

EV/EBITDA

11.0

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Yuan Dong Guo open_in_new

Employees

671

Founded

1999

Website

xzyy.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.8%	-0.4%	0.9%	-3.5%	-9.8%	-3.2%	14%	-9.5%	-9.9%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	600211 西藏诺迪康药业股份有限公司 Class A ISIN: CNE000000ZW7 Shares Out.: Shares Outstanding: 322.319M¹ Shares Float: 265.026M² TV: TradingView: SSE: 600211 SA: Stock Analysis: SHA: 600211 YF: Yahoo Finance: 600211.SS GF: Google Finance: SHA: 600211 BA: Barron's: 600211 MS: Morningstar: XSHG: 600211	40.46 CNY	TV: TradingView: SSE: 600211 SA: Stock Analysis: SHA: 600211 YF: Yahoo Finance: 600211.SS GF: Google Finance: SHA: 600211 BA: Barron's: 600211 MS: Morningstar: XSHG: 600211

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Tibet Rhodiola Pharmaceutical Holding Co.

Tibet Rhodiola Pharmaceutical Holding Co. produces and sells pharmaceutical products in China and internationally. The company offers modern Tibetan Medicines, including Nodikang capsules and granules, snow mountain golden arhat pain relief film, and ten-flavor Tida capsules; modern Chinese medicines, such as children Shuangqing granules, lipid clearing capsules, ginseng and zhi capsules, puyu capsules, and epilepsy flat film; and recombinant human brain natriuretic peptide for injection. It also provides isosorbide mononitrate sustained-release tablets; and oxygen rhodiola rosea moisturizing essence, secret recipe fragrance powder packet, rhodiola rosea, and Yuan Yang rhodiola rosea moisturizing essence products. In addition, the company offers biopharmaceuticals, traditional Chinese medicine, and chemical drugs for various fields, such as cardiovascular and cerebrovascular diseases, hepatobiliary diseases, orthopedic pain relief, rheumatism, and cold medicines. The company was founded in 1999 and is headquartered in Lhasa, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.89B 364.89B CNY 3K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.67B 336.36B CNY 2K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 1K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 859%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 743%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 717%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 39K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 28K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 18K%	97.4	United States
Roche Holding AG SIX: RO	$322.73B 256.25B CHF 16K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.3B 215.59B GBP 15K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.68B 218.9B CHF 14K%	20.5	Switzerland

chevron_leftBack